Publications

Check our publications

Publications

Since 2007 GENVIP has published more than 430 publications

Showing 0 de
0 publications
highlight
Reset everything

Año

Reset

Journal

Reset
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
TRANSLATING MENINGOCOCCAL SEROGROUP B VACCINES FOR HEALTHCARE PROFESSIONALS
Safadi MAP, Martinón-Torres F, Serra L, Burman C, Presa J
Journal:
Expert Rev Vaccines
Publicación independiente
Impact factor
5.217
Q2
VENTRICULAR REPOLARIZATION PARAMETERS AND CORONARY INVOLVEMENT IN KAWASAKI DISEASE
Barrios-Tascón A, Miura M, Domínguez-Rodríguez S, Fernández-Cooke E, Sarquella-Brugada G, Tagarro A; KAWA-RACE study group, (Martinón-Torres F)
Journal:
J Pediatr
Publicación independiente
Impact factor
4.406
Q1
Year:
2021
Doi:
CASE REPORT: TWO MONOCHORIONIC TWINS WITH A CRITICALLY DIFFERENT COURSE OF PROGRESSIVE OSSEUS HETEROPLASIA
Justicia-Grande AJ, Gómez-Ríal J, Rivero-Calle I, Pischedda S, Curras-Tuala MJ, Gómez-Carballa A, Cebey-López M, Pardo-Seco J, Méndez-Gallart R, Fernández-Seara MJ, Salas A, Martinón-Torres F
Journal:
Front Pediatr
Publicación independiente
Impact factor
3.418
Q1
INTERFERON-GAMMA RELEASE ASSAYS DIFFERENTIATE BETWEEN MYCOBACTERIUM AVIUM COMPLEX AND TUBERCULOUS LYMPHADENITIS IN CHILDREN
Martínez-Planas A, Baquero-Artigao F, Santiago B, Fortuny C, Méndez-Echevarría A, Del Rosal T, Bustillo-Alonso M, Gale I, Guerrero C, Blázquez-Gamero D, Canet A, Lillo M, Calavia O, Núñez Cuadros E, Falcón-Neyra L, Soriano-Arandes A, Van Ingen J, Tebruegge M, Noguera-Julian A; Spanish Pediatric TB Research Network (pTBred) and the European NontuberculouS MycoBacterial Lymphadenitis in childrEn (ENSeMBLE) Study. (Federico Martinón Torres)
Journal:
J Pediatr
Publicación independiente
Impact factor
4.406
Q1
Year:
2021
Doi:
TREATMENT OF MULTISYSTEM INFLAMMATORY SYNDROME IN CHILDREN
McArdle AJ, Vito O, Patel H, Seaby EG, Shah P, Wilson C, Broderick C, Nijman R, Tremoulet AH, Munblit D, Ulloa-Gutierrez R, Carter MJ, De T, Hoggart C, Whittaker E, Herberg JA, Kaforou M, Cunnington AJ, Levin M; BATS Consortium; (Federico Martinón Torres)
Journal:
N Engl J Med
Publicación independiente
Impact factor
91.253
Q1
Year:
2021
Doi:
DEVELOPMENT AND VALIDATION OF A PREDICTION MODEL FOR INVASIVE BACTERIAL INFECTIONS IN FEBRILE CHILDREN AT EUROPEAN EMERGENCY DEPARTMENTS: MOFICHE, A PROSPECTIVE OBSERVATIONAL STUDY
Hagedoorn NN, Borensztajn D, Nijman RG, Nieboer D, Herberg JA, Balode A, von Both U, Carrol E, Eleftheriou I, Emonts M, van der Flier M, de Groot R, Kohlmaier B, Lim E, Maconochie I, Martinón-Torres F, Pokorn M, Strle F, Tsolia M, Zavadska D, Zenz W, Levin M, Vermont C, Moll HA
Journal:
Arch Dis Child
Publicación independiente
Impact factor
3.801
Q1
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination
Schaffner, T. O.; Martinon-Torres F; Banzhoff, A; Azzari, C;De Wals, P; Marlow, R; Marshall, H; Pizza, M; Rappuoli, R; Bekkat, Berkani R.
Journal:
Swiss Medical Weekly
Publicación independiente
Impact factor
2.193
Q3
Recent advances in meningococcal B disease prevention: real-world evidence from 4CMenB vaccination
Martinón-Torres F, Banzhoff A, Azzari C, De Wals P, Marlow R, Marshall H, Pizza M, Rappuoli R, Berkani RB
Journal:
J Infect
Publicación independiente
Impact factor
6.072
Q1
IDENTIFICATION OF NOVEL LOCUS ASSOCIATED WITH CORONARY ARTERY ANEURYSMS AND VALIDATION OF LOCI FOR SUSCEPTIBILITY TO KAWASAKI DISEASE
Hoggart C, Shimizu C, Galassini R, Wright VJ, Shailes H, Bellos E, Herberg JA, Pollard AJ, O'Connor D, Choi SW, Seaby EG, Menikou S, Hibberd M, Sallah N, Burgner D, Brogan P, Patel H, Kim J, Tremoulet AH, Salo E, van Stijn D, Kuijpers T, Burns JC, Levin M; International Kawasaki Disease Genetics Consortium; UK Kawasaki Disease Genetics Consortium; EUCLIDS Consortium (Martinón Torres Federico)
Journal:
Eur J Hum Genet
Publicación independiente
Impact factor
4.246
Q2
Year:
2021
Doi:
TIPICO X: REPORT OF THE 10TH INTERACTIVE INFECTIOUS DISEASE WORKSHOP ON INFECTIOUS DISEASES AND VACCINES
Rivero-Calle I, Gómez-Rial J, Bont L, Gessner BD, Kohn M, Dagan R, Payne DC, Bruni L, Pollard AJ, García-Sastre A, Faustman DL, Osterhaus A, Butler R, Giménez Sánchez F, Álvarez F, Kaforou M, Bello X, Martinón-Torres F
Journal:
Hum Vaccine Immunother
Publicación independiente
Impact factor
3.452
Q2
IDENTIFICATION OF A MINIMAL 3-TRANSCRIPT SIGNATURE TO DIFFERENTIATE VIRAL FROM BACTERIAL INFECTION FROM BEST GENOME-WIDE HOST RNA BIOMARKERS: A MULTI-COHORT ANALYSIS
Gómez-Carballa A, Barral-Arca R, Cebey-López M, Bello X, Pardo-Seco J, Martinón-Torres F, Salas A
Journal:
International J Molecular Sciences
Publicación independiente
Impact factor
5.924
Q1
Vacuna antigripal trivalente de alta dosis: seguridad e inmunogenicidad
Ortiz de Lejarazu R, Martinón Torres F, Gil de Miguel A, Díez Domingo J,Redondo Marguello E
Journal:
Rev. Esp Quimioter
Publicación independiente
Impact factor
1.553
Q4
BCG VACCINATION IMPROVES DTAP IMMUNE RESPONSES IN MICE AND IS ASSOCIATED WITH LOWER PERTUSSIS INCIDENCE IN ECOLOGICAL EPIDEMIOLOGICAL STUDIES
Broset E, Pardo-Seco J, Kanno AI, Aguilo N, Dacosta AI, Rivero-Calle I, Gonzalo-Asensio J, Locht C, Leite LCC, Martin C, Martinón-Torres F
Journal:
EBioMedicine
Publicación independiente
Impact factor
8.143
Q1
NEBULISED ALX-0171 FOR RESPIRATORY SYNCYTIAL VIRUS LOWER RESPIRATORY TRACT INFECTION IN HOSPITALISED CHILDREN: A DOUBLE-BLIND, RANDOMISED, PLACEBO-CONTROLLED, PHASE 2B TRIAL
Cunningham S, Piedra PA, Martinon-Torres F, Szymanski H, Brackeva B, Dombrecht E, Detalle L, Fleurinck C; RESPIRE study group
Journal:
Lancet Respir Med
Publicación independiente
Impact factor
30.700
Q1
IMPACT OF MATERNAL DIPHTHERIA-TETANUS-ACELLULAR PERTUSSIS VACCINATION ON PERTUSSIS BOOSTER IMMUNE RESPONSES IN TODDLERS: FOLLOW-UP OF A RANDOMIZED TRIAL
Martinón-Torres F, Halperin SA, Nolan T, Tapiéro B, Perrett KP, de la Cueva IS, García-Sicilia J, Stranak Z, Vanderkooi OG, Kosina P, Rumlarova S, Virta M, Arribas JMM, Miranda-Valdivieso M, Novas BA, Bozensky J, Ortega MJC, Amador JTR, Baca M, Palomino EE, Zuccotti GV, Janota J, Marchisio PG, Kostanyan L, Meyer N, Ceregido MA, Cheuvart B, Kuriyakose SO, Mesaros N
Journal:
Vaccines
Publicación independiente
Impact factor
3.641
Q3
ASSOCIATION OF RARE CYP39A1 VARIANTS WITH EXFOLIATION SYNDROME INVOLVING THE ANTERIOR CHAMBER OF THE EYE
Genetics of Exfoliation Syndrome Partnership, Li Z, Wang Z, Lee MC, Zenkel M, Peh E, Ozaki M, Topouzis F, Nakano S, Chan A, Chen S, Williams SEI, Orr A, Nakano M, Kobakhidze N, Zarnowski T, Popa-Cherecheanu A, Mizoguchi T, Manabe SI, Hayashi K, Kazama S, Inoue K, Mori Y, Miyata K, Sugiyama K, Higashide T, Chihara E, Ideta R, Ishiko S, Yoshida A, Tokumo K, Kiuchi Y, Ohashi T, Sakurai T, Sugimoto T, Chuman H, Aihara M, Inatani M, Mori K, Ikeda Y, Ueno M, Gaston D, Rafuse P, Shuba L, Saunders J, Nicolela M, Chichua G, Tabagari S, Founti P, Sim KS, Meah WY, Soo HM, Chen XY, Chatzikyriakidou A, Keskini C, Pappas T, Anastasopoulos E, Lambropoulos A, Panagiotou ES, Mikropoulos DG, Kosior-Jarecka E, Cheong A, Li Y, Lukasik U, Nongpiur ME, Husain R, Perera SA, Álvarez L, García M, González-Iglesias H, Cueto AFV, Cueto LFV, Martinón-Torres F, Salas A, Oguz Ç, Tamcelik N, Atalay E, Batu B, Irkec M, Aktas D, Kasim B, Astakhov YS, Astakhov SY, Akopov EL, Giessl A, Mardin C, Hellerbrand C, Cooke Bailey JN, Igo RP Jr, Haines JL, Edward DP, Heegaard S, Davila S, Tan P, Kang JH, Pasquale LR, Kruse FE, Reis A, Carmichael TR, Hauser M, Ramsay M, Mossböck G, Yildirim N, Tashiro K, Konstas AGP, Coca-Prados M, Foo JN, Kinoshita S, Sotozono C, Kubota T, Dubina M, Ritch R, Wiggs JL, Pasutto F, Schlötzer-Schrehardt U, Ho YS, Aung T, Tam WL, Khor CC
Journal:
JAMA
Publicación independiente
Impact factor
56.274
Q1
IMPACT OF A CLINICAL DECISION RULE ON ANTIBIOTIC PRESCRIPTION FOR CHILDREN WITH SUSPECTED LOWER RESPIRATORY TRACT INFECTIONS PRESENTING TO EUROPEAN EMERGENCY DEPARTMENTS: A SIMULATION STUDY BASED ON ROUTINE DATA
Hagedoorn NN, Wagenaar JHL, Nieboer D, Bath D, Von Both U, Carrol ED, Eleftheriou I, Emonts M, Van Der Flier M, De Groot R, Herberg J, Kohlmaier B, Levin M, Lim E, Maconochie I, Martinon-Torres F, Nijman R, Pokorn M, Rivero Calle I, Tsolia M, Yeung S, Zavadska D, Zenz W, Vermont CL, Oostenbrink R, Moll HA
Journal:
J Antimicrob Chemother
Publicación independiente
Impact factor
5.790
Q1
CAPPRIC STUDY-CHARACTERIZATION OF COMMUNITY-ACQUIRED PNEUMONIA IN SPANISH ADULTS MANAGED IN PRIMARY CARE SETTINGS
Molina J, González-Gamarra A, Ginel L, Peláez ME, Juez JL, Artuñedo A, Aldana G, Quesada E, Cabré JJ, Gómez A, Linares M, Marín MT, Yolanda Sanchez P, Núñez L, Gonzálvez J, Mascarós E, López J, Cano A, Herrero J, Carmen Serra M, Cimas E, Pedrol M, Alfaro JV, Martinón-Torres F, Cifuentes I, Méndez C, Ocaña D, On Behalf Of The Cappric Study Group
Journal:
Microorganisms
Publicación independiente
Impact factor
4.128
Q2
PITFALLS OF BARCODES IN THE STUDY OF WORLDWIDE SARS-COV-2 VARIATION AND PHYLODYNAMICS.
Pardo-Seco J, Gómez-Carballa A, Bello X, Martinón-Torres F, Salas A.
Journal:
Zoological Research
Publicación independiente
Impact factor
4.560
Q1
HOST TRANSCRIPTOMIC RESPONSE FOLLOWING ADMINISTRATION OF ROTAVIRUS VACCINE IN INFANTS’ MIMICS WILD TYPE INFECTION
Gómez-Carballa A, Barral-Arca R, Cebey-López M, Currás-Tuala MJ, Pischedda S, Gómez-Rial J, Habgood-Coote D, Herberg JA, Kaforou M, Martinón-Torres F, Salas A
Journal:
Front. Immunol
Publicación independiente
Impact factor
7.561
Q1
Immunogenicity and safety of a quadrivalent meningococcal tetanus toxoid-conjugate vaccine (MenACYW-TT) vs. a licensed quadrivalent meningococcal tetanus toxoid-conjugate vaccine in meningococcal vaccine-naïve and meningococcal C conjugate vaccine-primed toddlers: a phase III randomised study
Van der Vliet D, Vesikari T, Sandner B, Martinón-Torres F, Muzsay G, Forsten A, Adelt T, Diaz Gonzalez C, Simko R, B'Chir S, Neveu D, Jordanov E, Dhingra MS
Journal:
Epidemiol Infect
Publicación independiente
Impact factor
2.455
Q3
REVIEW OF CLINICAL STUDIES COMPARING MENINGOCOCCAL SEROGROUP C IMMUNE RESPONSES INDUCED BY MENACWY-TT AND MONOVALENT SEROGROUP C VACCINES
Serra L, Knuf M, Martinón-Torres F, Yi K, Findlow J
Journal:
Hum Vaccin Immunother
Publicación independiente
Impact factor
3.452
Q2
VARIATION IN HOSPITAL ADMISSION IN FEBRILE CHILDREN EVALUATED AT THE EMERGENCY DEPARTMENT (ED) IN EUROPE: PERFORM, A MULTICENTRE PROSPECTIVE OBSERVATIONAL STUDY
Borensztajn DM, Hagedoorn NN, Rivero Calle I, Maconochie IK, von Both U, Carrol ED, Dewez JE, Emonts M, van der Flier M, de Groot R, Herberg J, Kohlmaier B, Lim E, Martinon-Torres F, Nieboer D, Nijman RG, Pokorn M, Strle F, Tsolia M, Vermont C, Yeung S, Zavadska D, Zenz W, Levin M, Moll HA; PERFORM consortium: Personalised Risk assessment in febrile children to optimise Real-life Management across the European Union children to optimise Real-life Management across the European Union
Journal:
PLoS One
Publicación independiente
Impact factor
3.240
Q2
No results found.
SAFETY AND IMMUNOGENICITY OF PNEUMOCOCCAL CONJUGATE VACCINES IN PRETERM INFANTS
Carolina López-Sanguos, Irene Rivero Calle, Carmen Rodriguez Tenreiro, Peter Francis Raguindin and Federico Martinón-Torres
Doi:
Expert Opin Drug Saf
Factor de impacto:
Q2
Doi:
¿QUÉ HEMOS APRENDIDO SOBRE ROTAVIRUS EN ESPAÑA EN LOS ÚLTIMOS 10 AÑOS?
Javier Díez-Domingo, María Garcés-Sánchez, Francisco Giménez-Sánchez, Javier Colomina-Rodríguez, Federico Martinón-Torres
Doi:
An Pediatr (Barc)
Factor de impacto:
Q3
Doi:
LIFESTYLE AND COMORBID CONDITIONS AS RISK FACTORS FOR COMMUNITY-ACQUIRED PNEUMONIA IN OUTPATIENT ADULTS (NEUMO-ES-RISK project)
Irene Rivero-Calle, Miriam Cebey-López, Jacobo Pardo-Seco, José Yuste, Esther Redondo, Diego A Vargas, Enrique Mascarós,Jose Luis Díaz-Maroto, Manuel Linares-Rufo, Isabel Jimeno, Angel Gil, Jesus Molina, Daniel Ocaña,Federico Martinón-Torres, on behalf of NEUMOEXPERTOS group
Doi:
BMJ Open Respir Res
Factor de impacto:
Doi:
EFFICACY, IMMUNOGENICITY, AND SAFETY OF A QUADRIVALENT INACTIVATED INFLUENZA VACCINE IN CHILDREN AGED 6–35 MONTHS: A MULTI-SEASON RANDOMISED PLACEBO-CONTROLLED TRIAL IN THE NORTHERN AND SOUTHERN HEMISPHERES
Stephanie Pepin, Martin Dupuy, Charissa Fay Corazon Borja-Tabora, May Montellanoc, Lulu Bravo, Jaime Santos, Jo-Anne de Castro, Doris Maribel Rivera-Medina, Clare Cutland, Miguel Ariza, Javier Diez-Domingo, Celia Diaz Gonzalez, Federico Martinón-Torres, Efimia Papadopoulou-Alataki, Maria Theodoriadou, Marie Pierre Kazek-Duret, Sanjay Gurunathan, Iris De Bruijn, for the GQM05 Study Group
Doi:
Vaccine
Factor de impacto:
Q2
Doi:
ROTAVIRUS INFECTION BEYOND THE GUT
José Gómez-Rial, Sonia Sánchez-Batán, Irene Rivero-Calle, Jacobo Pardo-Seco, José María Martinón-Martínez, Antonio Salas, Federico Martinón-Torres
Doi:
Infection and Drug Resistance
Factor de impacto:
Q2
Doi:
IMPLEMENTING UNIVERSAL VARICELLA VACCINATION IN EUROPE: THE PATH FORWARD
Vana Spoulou, Sophie Alain, Giovanni Gabutti, Carlo Giaquinto, Johannes Liese, Federico Martinon-Torres and Timo Vesikari
Doi:
Pediatric Infect Dis J
Factor de impacto:
Q2
Doi:
Descripción de la gripe B en las epidemias estacionales de España
Raúl Ortiz de Lejarazu, Javier Diez Domingo, Ángel Gil de Miguel, Federico Martinón-Torres, Carlos Guzmán Quilo, José María Guillén, Blanca Piedrafita, Esther Redondo Marguello
Doi:
Rev, Esp. Quimioterapia
Factor de impacto:
Q4
Doi:
EVALUATION OF A HEXAVALENT-PENTAVALENT-HEXAVALENT INFANT PRIMARY VACCINATION SERIESFOLLOWED BY A PENTAVALENT BOOSTER VACCINE IN HEALTHY INFANTS AND TODDLERS
Federico Martinόn-Torres, Javier Diez-Domingo, Emmanuel Feroldi, Emilia Jordanov, Siham B’Chir, and Xavier Da Costa, Hospital Clinico Universitario de Santiago de Compostela, Spain;FISABIO-Public Health,Valencia, Spain; Sanofi Pasteur, France; Sanofi Pasteur, USA
Doi:
Pediatric Infect Dis J
Factor de impacto:
Q2
Doi:
ANAMNESTIC IMMUNE RESPONSE AND SAFETY OF AN INACTIVATED QUADRIVALENT INFLUENZA VACCINE IN PRIMED VERSUS VACCINE-NAÏVE CHILDREN
Claeys C, Chandrasekaran V, García-Sicilia J, Prymula R, Díez-Domingo J, Brzostek J, Marès-Bermúdez J, Martinón-Torres, Pollard AJ, Růžková R, Martinez AC, Ulied A, Valdivieso MM, Faust SN, Snape MD, Friel D, Ollinger T, Soni J, Schuind A, Li P, Innis BL, Jain VK.
Doi:
Pediatric Infect Dis J
Factor de impacto:
Q2
Doi:
ADULT COMMUNITY ACQUIRED PNEUMONIA VACCINATION: 2018 UPDATE OF THE POSITIONING OF THE PNEUMONIA PREVENTION EXPERT GROUP
Redondo E, Rivero-Calle I, Vargas DA, Mascarós E, Díaz-Maroto JL, Linares M, Gil A, Molina J, Jimeno I, Ocaña D, Yuste JE, Martinón-Torres F, en nombre de Neumoexpertos en Prevención
Doi:
Semergen
Factor de impacto:
Doi:
ROUTINE INFANT VACCINATION OF PNEUMOCOCCAL CONJUGATE VACCINES HAS DECREASED PNEUMONIA ACROSS ALL AGE GROUPS IN NORTHERN SPAIN
I. Rivero-Calle, J. Pardo Seco, P. F. Raguindin, F. Alvez, J. Gómez-Rial, A. Salas, J. Martinón Sanchez and F. Martinón-Torres
Hum Vaccine Immunother
Factor de impacto:
Q2
Doi:
QUADRIVALENT INFLUENZA VACCINE PREVENTS ILLNESS AND REDUCES HEALTHCARE UTILIZATION ACROSS DIVERSE GEOGRAPHIC REGIONS DURING FIVE INFLUENZA SEASONS. A RANDOMIZED CLINICAL TRIAL
Ghassan Dbaibo, Arshad Amanullah, Carine Claeys, Allen Izu, Varsha K. Jain, Pope Kosalaraksa, Luis Rivera, Jyoti Soni, Emad Yanni, Khalequ Zaman, Beatriz Acosta, Miguel Ariza, Maria L. Arroba Basanta, Ashish Bavdekar, Alfonso Carmona, Luis Cousin, Jasur Danier, Alfonso Diaz, Javier Diez-Domingo, Ener C. Dinleyici, Saul N. Faust, Jose Garcia-Sicilia, Grace D. Gomez-Go, Maria L. A. Gonzales, Mustafa Hacimustafaoglu, Stephen M. Hughes, Teresa Jackowska, Shashi Kant, Marilla Lucero, Josep Mares Bermudez, Federico Martinón-Torres, May Montellano, Roman Prymula, Thanyawee Puthanakit, Renata Ruzkova, Iwona Sadowska-Krawczenko Henryk Szymanski, Angels Ulied, Wayne Woo, Anne Schuind and Bruce L. Innis for the Flu4VEC Study Group
Pediatr Infect Dis J
Factor de impacto:
Doi: